ÂÜÀòÂÒÂ×

James is responsible for all the company’s financial functions, including accounting, audit, treasury, corporate finance, investor relations, and strategic capital market relations.

Prior to joining BPGbio in 2023, James served as CFO at Ethos Risk Services, a global risk management firm wherein he helped drive corporate strategy growing the company from a Southeast US regional competitor to a global brand recognized as one of the industry’s top 3 firms. From 2012-2015, James led finance teams at Life Technologies (acquired by Thermo Fisher Scientific in 2013), where he managed the company’s global financial consolidation efforts. Early in his career, James advised and transacted on healthcare and tech deals across N America and Asia at JPMorgan and Credit Suisse, culminating in NASDAQ listings, private placements, and M&A transactions for the bank’s clients.

James received his MBA in Finance from Brigham Young University’s Marriott School of Business, where he was named an Eccles Scholar.